Cancer and COVID-19

Government allocated more than 20 billion rubles for medicines for COVID-19

  • 26.01.2022

Over 15 billion rubles will be allocated to medications not registered in Russia for the treatment of patients in hospitals - the authorities will purchase 200 thousand packages of molnupiravir and 78,456 packages of thixagevimab + cilgavimab, as well as about 3.1 thousand bottles of sotrovimab and approximately 515 thousand packages of remdesivir.

Original article
astrazeneca
olympus
philips
amteo
Ирвин 2
sanofi
roche
Р-ФАРМ
АМИ
sotio
novartis
exactsciences
takeda
bms